Aminoglycoside Antibacterial [EPC]

Aminoglycoside Antibacterial [EPC] was reported 44588 times

Drugs of the Aminoglycoside Antibacterial [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 AQUEOUS FIBRIN 24 0.4706
1 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1640 0.3010
2 CYSTIC FIBROSIS LUNG 37 0.2891
3 MYCOBACTERIUM ABSCESSUS INFECTION 187 0.2615
4 CYSTIC FIBROSIS 1327 0.2394
5 INFECTIVE EXACERBATION OF BRONCHIECTASIS 68 0.2215
6 CHOROIDITIS 73 0.1952
7 CYSTIC FIBROSIS RELATED DIABETES 28 0.1918
8 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 163 0.1825
9 MYCOBACTERIUM FORTUITUM INFECTION 32 0.1730
10 MYCOBACTERIUM AVIUM COMPLEX INFECTION 420 0.1563
11 OTOTOXICITY 279 0.1507
12 SPUTUM INCREASED 325 0.1501
13 GEOTRICHUM INFECTION 31 0.1469
14 INCREASED VISCOSITY OF BRONCHIAL SECRETION 85 0.1332
15 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 28 0.1267
16 BRONCHOSCOPY 30 0.1266
17 KERATITIS FUNGAL 25 0.1202
18 PULMONARY FUNCTION TEST DECREASED 470 0.1073
19 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 42 0.1034
20 PULMONARY RESECTION 24 0.0968
21 CORNEAL INFILTRATES 28 0.0892
22 DISTAL INTESTINAL OBSTRUCTION SYNDROME 30 0.0890
23 SPUTUM RETENTION 86 0.0868
24 LUNG INFECTION PSEUDOMONAL 48 0.0860
25 PSEUDOMONAS INFECTION 711 0.0828
26 CORNEAL EPITHELIUM DEFECT 46 0.0792
27 MYCOBACTERIUM CHELONAE INFECTION 58 0.0785
28 DEPENDENCE ON OXYGEN THERAPY 38 0.0771
29 BURKHOLDERIA CEPACIA COMPLEX INFECTION 22 0.0769
30 HYPOPYON 62 0.0749
31 RESPIRATORY TRACT IRRITATION 78 0.0747
32 PSEUDOMONAS TEST POSITIVE 60 0.0733
33 TRICHOSPORON INFECTION 29 0.0716
34 PANCREATIC INSUFFICIENCY 24 0.0670
35 SPUTUM ABNORMAL 42 0.0633
36 PNEUMONIA PSEUDOMONAL 95 0.0619
37 CORNEAL PERFORATION 37 0.0586
38 DEVICE MAINTENANCE ISSUE 33 0.0561
39 TRACHEITIS 40 0.0525
40 HYPOTONY OF EYE 22 0.0524
41 CORNEAL OPACITY 71 0.0520
42 BRONCHIECTASIS 346 0.0513
43 LUNG TRANSPLANT REJECTION 33 0.0500
44 ACINETOBACTER INFECTION 53 0.0484
45 BACTERIAL DISEASE CARRIER 35 0.0480
46 PULMONARY CAVITATION 41 0.0471
47 TOXIC ANTERIOR SEGMENT SYNDROME 51 0.0467
48 FORCED EXPIRATORY VOLUME DECREASED 132 0.0465
49 APHONIA 649 0.0465
50 MYCOBACTERIAL INFECTION 80 0.0464
51 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 23 0.0450
52 SCEDOSPORIUM INFECTION 31 0.0439
53 RESPIRATORY TRACT INFECTION FUNGAL 23 0.0436
54 RETINOPATHY OF PREMATURITY 23 0.0415
55 STENOTROPHOMONAS INFECTION 56 0.0413
56 BRONCHIAL SECRETION RETENTION 52 0.0408
57 VESTIBULAR DISORDER 50 0.0408
58 DEAFNESS NEUROSENSORY 134 0.0407
59 OCULAR HYPERTENSION 79 0.0407
60 FUSARIUM INFECTION 28 0.0400
61 LUNG TRANSPLANT 136 0.0384
62 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 35 0.0378
63 HYPERSENSITIVITY PNEUMONITIS 43 0.0378
64 PATHOGEN RESISTANCE 337 0.0369
65 CONJUNCTIVAL HYPERAEMIA 130 0.0364
66 SPUTUM CULTURE POSITIVE 29 0.0357
67 SERRATIA INFECTION 26 0.0349
68 ATYPICAL MYCOBACTERIAL INFECTION 49 0.0346
69 CONJUNCTIVAL OEDEMA 35 0.0340
70 SPUTUM DISCOLOURED 323 0.0340
71 OXYGEN THERAPY 55 0.0334
72 HAEMOPTYSIS 920 0.0329
73 SYSTEMIC CANDIDA 80 0.0318
74 ULCERATIVE KERATITIS 85 0.0310
75 CORNEAL OEDEMA 69 0.0308
76 ENDOPHTHALMITIS 184 0.0306
77 FUNGAEMIA 48 0.0305
78 DRUG RESISTANCE 765 0.0298
79 INCREASED BRONCHIAL SECRETION 75 0.0293
80 KERATITIS 88 0.0289
81 MULTIPLE-DRUG RESISTANCE 85 0.0274
82 NOCARDIOSIS 69 0.0270
83 CHRONIC RESPIRATORY FAILURE 32 0.0265
84 DEAFNESS BILATERAL 44 0.0259
85 PULMONARY FUNCTION TEST ABNORMAL 40 0.0257
86 PRODUCT PACKAGING DIFFICULT TO OPEN 67 0.0257
87 VITRITIS 46 0.0248
88 NASAL INFLAMMATION 25 0.0237
89 BRONCHOSPASM 336 0.0235
90 ASPERGILLUS INFECTION 154 0.0234
91 RHONCHI 32 0.0232
92 DYSPHONIA 1354 0.0231
93 LINEAR IGA DISEASE 38 0.0228
94 ENTEROCOCCAL INFECTION 108 0.0223
95 KLEBSIELLA INFECTION 113 0.0223
96 PRODUCTIVE COUGH 1055 0.0221
97 CARBON DIOXIDE INCREASED 30 0.0220
98 TOTAL LUNG CAPACITY DECREASED 35 0.0219
99 BRAIN ABSCESS 55 0.0217
100 THERAPY INTERRUPTED 1548 0.0216
101 PNEUMONIA STAPHYLOCOCCAL 41 0.0208
102 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 51 0.0206
103 REHABILITATION THERAPY 79 0.0204
104 NEPHROPATHY TOXIC 229 0.0204
105 APLASTIC ANAEMIA 105 0.0201
106 SECRETION DISCHARGE 251 0.0200
107 MUCORMYCOSIS 52 0.0200
108 CENTRAL VENOUS CATHETERISATION 60 0.0199
109 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 120 0.0197
110 LUNG INFECTION 305 0.0196
111 LUNG ABSCESS 41 0.0195
112 PULMONARY PAIN 57 0.0195
113 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 97 0.0194
114 HYPERLACTACIDAEMIA 52 0.0194
115 SINUS OPERATION 46 0.0193
116 PULMONARY HAEMORRHAGE 151 0.0193
117 DEAFNESS 499 0.0191
118 STAPHYLOCOCCUS TEST POSITIVE 40 0.0190
119 RENAL TUBULAR INJURY 23 0.0189
120 RENAL TUBULAR NECROSIS 181 0.0184
121 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 131 0.0183
122 RHINOVIRUS INFECTION 68 0.0175
123 MECHANICAL VENTILATION 33 0.0174
124 DACRYOSTENOSIS ACQUIRED 22 0.0170
125 INTENSIVE CARE 24 0.0169
126 PNEUMONIA KLEBSIELLA 31 0.0168
127 EMERGENCY CARE 51 0.0168
128 PSEUDOMEMBRANOUS COLITIS 37 0.0166
129 PSEUDOMONAL SEPSIS 29 0.0165
130 APLASIA 32 0.0163
131 EYELID PAIN 33 0.0162
132 INTRAOCULAR PRESSURE INCREASED 207 0.0162
133 HOSPITALISATION 2482 0.0161
134 BRONCHOPULMONARY ASPERGILLOSIS 125 0.0161
135 BRONCHIAL DISORDER 25 0.0161
136 HYPERPARATHYROIDISM SECONDARY 40 0.0159
137 CORNEAL DISORDER 35 0.0159
138 OPTIC NEUROPATHY 33 0.0156
139 NEPHROGENIC ANAEMIA 72 0.0155
140 PNEUMONIA FUNGAL 59 0.0149
141 UNDERWEIGHT 29 0.0147
142 PARADOXICAL DRUG REACTION 54 0.0147
143 PAINFUL RESPIRATION 35 0.0145
144 LIVING IN RESIDENTIAL INSTITUTION 27 0.0144
145 PHYSICAL DECONDITIONING 37 0.0144
146 LOWER RESPIRATORY TRACT CONGESTION 24 0.0141
147 LUNG DISORDER 685 0.0140
148 PNEUMOTHORAX 217 0.0137
149 INTENTIONAL DOSE OMISSION 388 0.0136
150 CANDIDA INFECTION 229 0.0135
151 REBOUND ACID HYPERSECRETION 41 0.0135
152 CHEST INJURY 28 0.0135
153 PNEUMONIA BACTERIAL 124 0.0135
154 BACTERIAL TEST POSITIVE 30 0.0134
155 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 346 0.0134
156 RESPIRATORY SYMPTOM 38 0.0133
157 CYSTOID MACULAR OEDEMA 25 0.0133
158 FEBRILE BONE MARROW APLASIA 56 0.0132
159 NOSOCOMIAL INFECTION 29 0.0132
160 HOSPICE CARE 130 0.0131
161 TINNITUS 603 0.0131
162 SWELLING OF EYELID 81 0.0129
163 SEPTIC SHOCK 559 0.0128
164 CREPITATIONS 38 0.0127
165 ERYTHEMA OF EYELID 69 0.0127
166 BLEPHARITIS 51 0.0127
167 CLOSTRIDIUM DIFFICILE COLITIS 134 0.0126
168 CHRONIC SINUSITIS 47 0.0125
169 RASH MORBILLIFORM 34 0.0123
170 FOREIGN BODY SENSATION IN EYES 78 0.0122
171 ADENOVIRUS INFECTION 35 0.0121
172 PATIENT DISSATISFACTION WITH TREATMENT 23 0.0119
173 TOXIC EPIDERMAL NECROLYSIS 181 0.0119
174 ESCHERICHIA SEPSIS 34 0.0117
175 RENAL TUBULAR DISORDER 33 0.0117
176 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 91 0.0117
177 RALES 68 0.0117
178 MULTIPLE ORGAN DYSFUNCTION SYNDROME 331 0.0117
179 RASH MACULO-PAPULAR 259 0.0116
180 HYPERCAPNIA 35 0.0116
181 NEUTROPENIC COLITIS 24 0.0116
182 HYPOPROTEINAEMIA 22 0.0116
183 DISEASE COMPLICATION 53 0.0116
184 TOOTH DISCOLOURATION 34 0.0115
185 OXYGEN SATURATION DECREASED 648 0.0115
186 RETINOPATHY 43 0.0115
187 COMPUTERISED TOMOGRAM ABNORMAL 26 0.0115
188 DISSEMINATED TUBERCULOSIS 29 0.0113
189 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 26 0.0112
190 EYELID IRRITATION 28 0.0112
191 COUGH 3088 0.0110
192 EOSINOPHILIA 192 0.0109
193 DEVICE CONNECTION ISSUE 23 0.0109
194 INFLAMMATORY MARKER INCREASED 54 0.0109
195 BACTERIAL INFECTION 200 0.0107
196 INSURANCE ISSUE 162 0.0106
197 DRUG LEVEL INCREASED 175 0.0106
198 BACTERIAL SEPSIS 34 0.0104
199 TOXIC SKIN ERUPTION 105 0.0104
200 EYE PAIN 581 0.0103
201 JAW FRACTURE 22 0.0102
202 ANGLE CLOSURE GLAUCOMA 26 0.0102
203 HEPATOSPLENOMEGALY 26 0.0101
204 OXYGEN CONSUMPTION INCREASED 24 0.0100
205 BLOOD CULTURE POSITIVE 30 0.0100
206 EYELID DISORDER 23 0.0100
207 LYMPHADENITIS 24 0.0099
208 PNEUMATOSIS INTESTINALIS 28 0.0098
209 EYE OEDEMA 24 0.0098
210 STAPHYLOCOCCAL INFECTION 321 0.0097
211 ESCHERICHIA INFECTION 80 0.0097
212 GUILLAIN-BARRE SYNDROME 47 0.0097
213 PULMONARY CONGESTION 127 0.0096
214 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 31 0.0095
215 HYDROCEPHALUS 52 0.0095
216 LUNG OPACITY 25 0.0095
217 RESPIRATORY SYNCYTIAL VIRUS INFECTION 82 0.0094
218 LUNG CONSOLIDATION 26 0.0093
219 OCULAR DISCOMFORT 104 0.0093
220 BLOOD CREATININE DECREASED 29 0.0093
221 LIVER ABSCESS 30 0.0092
222 HORDEOLUM 40 0.0092
223 EYELID OEDEMA 107 0.0092
224 ORAL CANDIDIASIS 120 0.0091
225 UVEITIS 123 0.0091
226 RESPIRATORY DISTRESS 250 0.0090
227 ACUTE RESPIRATORY DISTRESS SYNDROME 159 0.0090
228 ACCIDENTAL UNDERDOSE 129 0.0090
229 CONJUNCTIVITIS 165 0.0089
230 EYE INFECTION 100 0.0088
231 RESPIRATION ABNORMAL 61 0.0088
232 PHOTOPHOBIA 165 0.0088
233 BACTERAEMIA 104 0.0088
234 RESPIRATORY TRACT CONGESTION 139 0.0087
235 STAPHYLOCOCCAL SEPSIS 43 0.0087
236 OROPHARYNGEAL DISCOMFORT 78 0.0086
237 HYPERBILIRUBINAEMIA 88 0.0085
238 ELECTROCARDIOGRAM QT PROLONGED 302 0.0084
239 EYELIDS PRURITUS 26 0.0083
240 HYPERTRANSAMINASAEMIA 58 0.0083
241 OCULAR HYPERAEMIA 390 0.0082
242 OLIGURIA 51 0.0082
243 DERMATITIS EXFOLIATIVE 41 0.0082
244 EYE DISCHARGE 85 0.0082
245 ACUTE KIDNEY INJURY 1251 0.0082
246 CONJUNCTIVAL HAEMORRHAGE 31 0.0081
247 WHEEZING 476 0.0080
248 ILL-DEFINED DISORDER 480 0.0079
249 HAEMODYNAMIC INSTABILITY 59 0.0077
250 HEPATOTOXICITY 172 0.0077
251 VASCULAR DEVICE INFECTION 35 0.0077
252 VASCULITIS 89 0.0076
253 RESPIRATORY FAILURE 549 0.0075
254 ABSCESS LIMB 32 0.0075
255 INFECTION 1085 0.0075
256 ORGANISING PNEUMONIA 37 0.0075
257 END STAGE RENAL DISEASE 136 0.0074
258 CONCOMITANT DISEASE AGGRAVATED 46 0.0074
259 EAR DISCOMFORT 76 0.0074
260 MULTI-ORGAN FAILURE 128 0.0074
261 RETINAL DETACHMENT 68 0.0074
262 THROAT IRRITATION 330 0.0073
263 FAILURE TO THRIVE 38 0.0073
264 MACULAR OEDEMA 41 0.0073
265 BREATH SOUNDS ABNORMAL 36 0.0073
266 IRIDOCYCLITIS 23 0.0073
267 HYPOACUSIS 313 0.0073
268 LUNG INFILTRATION 64 0.0072
269 RESPIRATORY DISORDER 216 0.0072
270 ACUTE RESPIRATORY FAILURE 138 0.0072
271 PNEUMONIA 2316 0.0071
272 EXERCISE TOLERANCE DECREASED 41 0.0071
273 ENTEROCOLITIS 41 0.0071
274 PULMONARY TOXICITY 50 0.0071
275 EYE INFLAMMATION 67 0.0070
276 OBSTRUCTIVE AIRWAYS DISORDER 78 0.0070
277 SOCIAL PROBLEM 29 0.0070
278 DRY THROAT 71 0.0070
279 VISUAL ACUITY REDUCED 232 0.0070
280 MALNUTRITION 78 0.0070
281 LACRIMATION INCREASED 209 0.0069
282 LEUKOCYTOSIS 124 0.0068
283 PULMONARY MASS 102 0.0068
284 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 357 0.0068
285 DRUG INTOLERANCE 659 0.0068
286 CLOSTRIDIAL INFECTION 23 0.0068
287 GENERAL PHYSICAL CONDITION ABNORMAL 46 0.0068
288 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 40 0.0067
289 CANDIDIASIS 27 0.0067
290 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 34 0.0067
291 BLOOD ALBUMIN DECREASED 53 0.0067
292 STREPTOCOCCAL INFECTION 37 0.0066
293 GRANULOMA 23 0.0066
294 TONGUE DISCOLOURATION 29 0.0066
295 ATELECTASIS 64 0.0066
296 PULMONARY TUBERCULOSIS 28 0.0065
297 PARANASAL SINUS HYPERSECRETION 25 0.0065
298 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 25 0.0065
299 RESPIRATORY RATE INCREASED 58 0.0065
300 CHEST DISCOMFORT 662 0.0065
301 ORGAN FAILURE 26 0.0064
302 HYPERACUSIS 24 0.0064
303 TRANSPLANT REJECTION 51 0.0064
304 HAEMODIALYSIS 53 0.0063
305 PATENT DUCTUS ARTERIOSUS 25 0.0063
306 RESPIRATORY TRACT INFECTION 163 0.0063
307 HAEMOLYTIC ANAEMIA 56 0.0062
308 HYPOXIA 219 0.0062
309 MACULOPATHY 22 0.0062
310 ELECTROLYTE IMBALANCE 72 0.0062
311 EYE IRRITATION 356 0.0062
312 COAGULOPATHY 103 0.0062
313 POLYNEUROPATHY 73 0.0061
314 ARTHRITIS BACTERIAL 25 0.0061
315 VENOOCCLUSIVE LIVER DISEASE 30 0.0061
316 WALKING AID USER 40 0.0061
317 DYSPNOEA EXERTIONAL 228 0.0060
318 ABNORMAL SENSATION IN EYE 26 0.0060
319 BLOOD UREA INCREASED 101 0.0060
320 HYPERNATRAEMIA 30 0.0060
321 OROPHARYNGEAL PAIN 556 0.0060
322 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 45 0.0060
323 DEAFNESS UNILATERAL 33 0.0060
324 HEPATIC CYTOLYSIS 76 0.0060
325 NEUTROPHIL COUNT INCREASED 61 0.0060
326 EYE SWELLING 221 0.0059
327 ANURIA 51 0.0059
328 HEPATOMEGALY 58 0.0059
329 CHRONIC KIDNEY DISEASE 444 0.0058
330 CACHEXIA 30 0.0058
331 THROMBOCYTOPENIA 648 0.0058
332 FEBRILE NEUTROPENIA 382 0.0058
333 STAPHYLOCOCCAL BACTERAEMIA 25 0.0057
334 EMPHYSEMA 58 0.0057
335 VIRAL INFECTION 190 0.0057
336 RENAL FAILURE ACUTE 242 0.0057
337 GRAFT VERSUS HOST DISEASE 41 0.0057
338 ACUTE PULMONARY OEDEMA 32 0.0057
339 CONDITION AGGRAVATED 1717 0.0056
340 DYSPNOEA 3189 0.0056
341 UPPER RESPIRATORY TRACT INFECTION 260 0.0056
342 CHOLESTASIS 108 0.0056
343 TUBULOINTERSTITIAL NEPHRITIS 105 0.0056
344 EYE PRURITUS 187 0.0056
345 CHEILITIS 30 0.0055
346 PANCYTOPENIA 309 0.0055
347 PROTHROMBIN TIME PROLONGED 33 0.0055
348 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 301 0.0055
349 CYTOPENIA 67 0.0055
350 FUNGAL INFECTION 182 0.0055
351 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 52 0.0054
352 SUBCUTANEOUS ABSCESS 26 0.0054
353 HYPERURICAEMIA 22 0.0053
354 ENCEPHALITIS 37 0.0053
355 ENCEPHALOPATHY 131 0.0053
356 TOXIC ENCEPHALOPATHY 27 0.0053
357 SHOCK HAEMORRHAGIC 43 0.0053
358 RENAL FAILURE 700 0.0053
359 ACUTE GRAFT VERSUS HOST DISEASE 24 0.0052
360 HERPES SIMPLEX 34 0.0052
361 SEPSIS 577 0.0052
362 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 88 0.0051
363 DISSEMINATED INTRAVASCULAR COAGULATION 72 0.0051
364 SUSPECTED OFF LABEL USE 23 0.0051
365 HEPATIC LESION 22 0.0051
366 HEPATOCELLULAR INJURY 72 0.0051
367 RETINAL HAEMORRHAGE 36 0.0050
368 SINUS DISORDER 100 0.0050
369 PROTEIN URINE PRESENT 25 0.0050
370 PERIORBITAL OEDEMA 26 0.0050
371 HEPATITIS CHOLESTATIC 30 0.0050
372 HYPERTHERMIA 38 0.0050
373 BONE MARROW FAILURE 101 0.0050
374 PRODUCT DISTRIBUTION ISSUE 46 0.0050
375 PERIORBITAL SWELLING 28 0.0049
376 PRODUCT SUPPLY ISSUE 35 0.0049
377 SKIN HYPERPIGMENTATION 42 0.0049
378 OFF LABEL USE 4278 0.0049
379 ENDOCARDITIS 25 0.0049
380 AORTIC ANEURYSM 37 0.0049
381 TRANSAMINASES INCREASED 108 0.0049
382 SKIN NECROSIS 25 0.0048
383 EAR DISORDER 22 0.0048
384 SINUS CONGESTION 64 0.0047
385 INTESTINAL ISCHAEMIA 26 0.0047
386 TACHYPNOEA 64 0.0047
387 OSTEOPENIA 71 0.0047
388 INCREASED UPPER AIRWAY SECRETION 24 0.0047
389 NASAL POLYPS 23 0.0047
390 LEUKOPENIA 233 0.0047
391 RENAL IMPAIRMENT 391 0.0046
392 STEVENS-JOHNSON SYNDROME 103 0.0046
393 CARDIAC TAMPONADE 22 0.0046
394 MUCOSAL INFLAMMATION 121 0.0046
395 SHOCK 106 0.0046
396 PLEURISY 27 0.0045
397 CLOSTRIDIUM DIFFICILE INFECTION 99 0.0045
398 SEASONAL ALLERGY 64 0.0045
399 CHOKING 88 0.0045
400 NEUROTOXICITY 79 0.0045
401 INCORRECT PRODUCT ADMINISTRATION DURATION 97 0.0045
402 PRODUCT DOSE OMISSION 292 0.0045
403 PROTEINURIA 85 0.0045
404 ADVERSE DRUG REACTION 401 0.0045
405 UNEVALUABLE EVENT 335 0.0044
406 TREATMENT FAILURE 365 0.0044
407 UPPER-AIRWAY COUGH SYNDROME 36 0.0044
408 ASTHENOPIA 24 0.0044
409 CHOLANGITIS 27 0.0044
410 ACIDOSIS 33 0.0043
411 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 207 0.0043
412 HYPERKALAEMIA 151 0.0043
413 ILLNESS 441 0.0043
414 HYPOALBUMINAEMIA 33 0.0042
415 RENAL INJURY 126 0.0042
416 POST PROCEDURAL COMPLICATION 81 0.0042
417 DRUG-INDUCED LIVER INJURY 132 0.0042
418 DYSGEUSIA 312 0.0042
419 MENINGITIS 28 0.0042
420 PNEUMOCYSTIS JIROVECII PNEUMONIA 42 0.0042
421 LEFT VENTRICULAR DYSFUNCTION 28 0.0042
422 CHOKING SENSATION 23 0.0042
423 BLOOD CREATININE INCREASED 272 0.0042
424 PRODUCT USE IN UNAPPROVED INDICATION 1031 0.0042
425 DIALYSIS 59 0.0042
426 DEVICE RELATED INFECTION 64 0.0042
427 PANCREATITIS ACUTE 93 0.0041
428 FACE OEDEMA 69 0.0041
429 INFLAMMATION 211 0.0041
430 PYREXIA 1414 0.0041
431 PURPURA 36 0.0041
432 DRUG PRESCRIBING ERROR 78 0.0041
433 TREATMENT NONCOMPLIANCE 220 0.0040
434 PNEUMONITIS 109 0.0040
435 SALIVARY HYPERSECRETION 40 0.0040
436 PRODUCT DOSE OMISSION ISSUE 1173 0.0040
437 EYE DISORDER 131 0.0040
438 INFUSION SITE SWELLING 25 0.0040
439 INFLUENZA 443 0.0040
440 OPTIC NEURITIS 36 0.0040
441 LOWER RESPIRATORY TRACT INFECTION 180 0.0040
442 GLAUCOMA 76 0.0039
443 PULMONARY HYPERTENSION 82 0.0039
444 PERIPHERAL SENSORY NEUROPATHY 23 0.0039
445 HYPOVOLAEMIA 23 0.0039
446 ASPIRATION 43 0.0039
447 CARDIOGENIC SHOCK 56 0.0039
448 STATUS EPILEPTICUS 44 0.0039
449 GLUCOSE TOLERANCE IMPAIRED 23 0.0039
450 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 66 0.0039
451 HYPOMAGNESAEMIA 54 0.0039
452 BLOOD BILIRUBIN INCREASED 104 0.0038
453 RETCHING 82 0.0038
454 ALANINE AMINOTRANSFERASE INCREASED 236 0.0038
455 DEVICE ISSUE 344 0.0038
456 MYOPATHY 33 0.0038
457 NEUROPATHY PERIPHERAL 363 0.0038
458 GENERALISED OEDEMA 47 0.0038
459 PLEURAL EFFUSION 228 0.0037
460 SKIN MASS 25 0.0037
461 LYMPHOCYTE COUNT DECREASED 66 0.0037
462 DERMATITIS BULLOUS 27 0.0037
463 MYASTHENIA GRAVIS 30 0.0037
464 EPSTEIN-BARR VIRUS INFECTION 23 0.0037
465 HAEMATOCRIT DECREASED 73 0.0037
466 TENDON DISORDER 24 0.0037
467 LYMPHOPENIA 52 0.0037
468 GASTROINTESTINAL DISORDER 328 0.0037
469 VENTRICULAR EXTRASYSTOLES 38 0.0037
470 TRICUSPID VALVE INCOMPETENCE 29 0.0036
471 LOW BIRTH WEIGHT BABY 29 0.0036
472 EYELID PTOSIS 37 0.0036
473 TUMOUR LYSIS SYNDROME 32 0.0036
474 ABSCESS 58 0.0036
475 RHINITIS 29 0.0036
476 BLOOD ALKALINE PHOSPHATASE INCREASED 89 0.0036
477 SMALL INTESTINAL OBSTRUCTION 44 0.0036
478 RASH PUSTULAR 26 0.0036
479 DRUG INTERACTION 566 0.0036
480 ECONOMIC PROBLEM 54 0.0036
481 ASPARTATE AMINOTRANSFERASE INCREASED 189 0.0036
482 BLOOD SODIUM DECREASED 67 0.0036
483 MOUTH HAEMORRHAGE 26 0.0035
484 REFUSAL OF TREATMENT BY PATIENT 23 0.0035
485 BEDRIDDEN 46 0.0035
486 DRUG ERUPTION 62 0.0035
487 EAR PAIN 68 0.0035
488 BRAIN OEDEMA 44 0.0035
489 EOSINOPHIL COUNT INCREASED 29 0.0035
490 ASTHMA 392 0.0035
491 HYPOKALAEMIA 160 0.0035
492 ILEUS 43 0.0035
493 CARDIAC FAILURE ACUTE 23 0.0034
494 WEIGHT DECREASED 962 0.0034
495 MUSCULOSKELETAL CHEST PAIN 53 0.0034
496 BRONCHITIS 252 0.0034
497 DEATH 2928 0.0034
498 MYELOSUPPRESSION 122 0.0034
499 PHARYNGITIS 42 0.0034
500 NEPHROLITHIASIS 155 0.0034
501 CYANOSIS 53 0.0034
502 NEUTROPENIC SEPSIS 24 0.0034
503 MITRAL VALVE INCOMPETENCE 38 0.0034
504 NEUTROPENIA 455 0.0033
505 EJECTION FRACTION DECREASED 52 0.0033
506 CYTOKINE RELEASE SYNDROME 67 0.0033
507 SINUS TACHYCARDIA 47 0.0033
508 SPINAL OSTEOARTHRITIS 29 0.0033
509 GAMMA-GLUTAMYLTRANSFERASE INCREASED 73 0.0033
510 GENERAL PHYSICAL HEALTH DETERIORATION 381 0.0033
511 TACHYCARDIA 292 0.0033
512 RENAL FAILURE CHRONIC 25 0.0032
513 BLINDNESS 132 0.0032
514 PRODUCT USE COMPLAINT 51 0.0032
515 WHITE BLOOD CELL COUNT INCREASED 124 0.0032
516 RIB FRACTURE 66 0.0032
517 DRUG DOSE OMISSION BY DEVICE 251 0.0032
518 HEPATITIS 82 0.0032
519 PULMONARY OEDEMA 143 0.0032
520 BLINDNESS UNILATERAL 45 0.0032
521 CYTOMEGALOVIRUS INFECTION 53 0.0032
522 DRY EYE 159 0.0032
523 VISUAL FIELD DEFECT 23 0.0032
524 CATARACT 189 0.0032
525 SKIN LESION 87 0.0032
526 METABOLIC ACIDOSIS 101 0.0032
527 RENAL DISORDER 147 0.0032
528 OSTEOMYELITIS 57 0.0031
529 EYE HAEMORRHAGE 42 0.0031
530 DRUG LEVEL DECREASED 32 0.0031
531 RHINORRHOEA 202 0.0031
532 MUSCLE STRAIN 27 0.0031
533 VISION BLURRED 424 0.0031
534 SINUSITIS 316 0.0031
535 INTESTINAL OBSTRUCTION 116 0.0031
536 IMPAIRED QUALITY OF LIFE 44 0.0031
537 WEIGHT FLUCTUATION 32 0.0031
538 TRANSFUSION 32 0.0031
539 CIRCULATORY COLLAPSE 52 0.0031
540 COVID-19 PNEUMONIA 36 0.0030
541 GASTROENTERITIS VIRAL 55 0.0030
542 EAR INFECTION 81 0.0030
543 SUPRAVENTRICULAR TACHYCARDIA 29 0.0030
544 PERICARDIAL EFFUSION 70 0.0030
545 LIVER FUNCTION TEST INCREASED 65 0.0030
546 RENAL CYST 24 0.0030
547 AGRANULOCYTOSIS 56 0.0030
548 PRODUCT USE ISSUE 566 0.0030
549 DEVICE PHYSICAL PROPERTY ISSUE 23 0.0030
550 VISUAL IMPAIRMENT 372 0.0030
551 THERAPY NON-RESPONDER 134 0.0030
552 NIGHT SWEATS 96 0.0030
553 ARTERIOSCLEROSIS 28 0.0030
554 JAUNDICE 80 0.0030
555 BODY TEMPERATURE INCREASED 60 0.0029
556 ANHEDONIA 77 0.0029
557 ACUTE HEPATIC FAILURE 40 0.0029
558 CARDIOMYOPATHY 43 0.0029
559 ERYTHEMA MULTIFORME 27 0.0029
560 EPISTAXIS 216 0.0029
561 PYELONEPHRITIS 25 0.0029
562 PULMONARY FIBROSIS 55 0.0029
563 PULMONARY THROMBOSIS 31 0.0028
564 DECUBITUS ULCER 23 0.0028
565 LACTIC ACIDOSIS 91 0.0028
566 HYPOTONIA 28 0.0028
567 C-REACTIVE PROTEIN INCREASED 102 0.0028
568 MALAISE 1224 0.0028
569 CHEST PAIN 516 0.0028
570 PETECHIAE 29 0.0028
571 EATING DISORDER 59 0.0028
572 ALTERED STATE OF CONSCIOUSNESS 60 0.0028
573 PNEUMONIA ASPIRATION 69 0.0028
574 HYPERSENSITIVITY 512 0.0028
575 HEPATIC FAILURE 83 0.0028
576 VITREOUS FLOATERS 27 0.0027
577 LYMPHADENOPATHY 97 0.0027
578 DISEASE PROGRESSION 324 0.0027
579 ORAL DISCOMFORT 38 0.0027
580 HYPERGLYCAEMIA 99 0.0027
581 DECREASED APPETITE 629 0.0027
582 GASTROOESOPHAGEAL REFLUX DISEASE 217 0.0027
583 CARDIAC ARREST 222 0.0027
584 TENDERNESS 28 0.0027
585 DEVICE USE ISSUE 47 0.0027
586 HAEMATURIA 92 0.0027
587 HYPERLIPIDAEMIA 32 0.0027
588 NEPHROPATHY 25 0.0027
589 PERITONITIS BACTERIAL 27 0.0027
590 HAEMORRHAGE INTRACRANIAL 40 0.0027
591 UNRESPONSIVE TO STIMULI 69 0.0027
592 VITAMIN D DEFICIENCY 26 0.0027
593 VENTRICULAR TACHYCARDIA 44 0.0027
594 PHOTOSENSITIVITY REACTION 44 0.0027
595 TENDONITIS 41 0.0026
596 URINE OUTPUT DECREASED 23 0.0026
597 DEVICE LEAKAGE 114 0.0026
598 ASCITES 77 0.0026
599 VENTRICULAR FIBRILLATION 29 0.0026
600 SLEEP DISORDER 184 0.0026
601 CELLULITIS 131 0.0026
602 ANAEMIA 495 0.0026
603 INTERVERTEBRAL DISC DEGENERATION 24 0.0026
604 MENTAL STATUS CHANGES 72 0.0026
605 HYPONATRAEMIA 145 0.0026
606 RASH ERYTHEMATOUS 123 0.0026
607 DRUG TOXICITY 35 0.0026
608 COMA 122 0.0026
609 SPLENOMEGALY 30 0.0026
610 FLANK PAIN 24 0.0026
611 TOOTH ABSCESS 26 0.0026
612 DERMATITIS CONTACT 29 0.0025
613 NASAL CONGESTION 149 0.0025
614 SURGERY 148 0.0025
615 HEART RATE INCREASED 249 0.0025
616 IMMUNOSUPPRESSION 22 0.0025
617 HEPATIC ENZYME INCREASED 168 0.0025
618 BLOOD PRESSURE SYSTOLIC INCREASED 48 0.0025
619 QUALITY OF LIFE DECREASED 33 0.0025
620 MUSCULOSKELETAL DISCOMFORT 42 0.0024
621 CARDIOMEGALY 30 0.0024
622 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 25 0.0024
623 MYOCLONUS 29 0.0024
624 PRESYNCOPE 59 0.0024
625 TASTE DISORDER 49 0.0024
626 FLUID OVERLOAD 35 0.0024
627 NERVOUS SYSTEM DISORDER 75 0.0024
628 DISEASE RECURRENCE 114 0.0024
629 INTERNATIONAL NORMALISED RATIO INCREASED 68 0.0024
630 GRAND MAL CONVULSION 22 0.0024
631 HYPOTHERMIA 24 0.0024
632 THROAT TIGHTNESS 64 0.0024
633 HEPATIC STEATOSIS 44 0.0024
634 CHILLS 276 0.0024
635 GALLBLADDER DISORDER 42 0.0024
636 IMMUNE SYSTEM DISORDER 31 0.0023
637 HYPOTENSION 470 0.0023
638 BLOOD POTASSIUM INCREASED 38 0.0023
639 LIVER FUNCTION TEST ABNORMAL 68 0.0023
640 BODY TEMPERATURE DECREASED 23 0.0023
641 LIGAMENT SPRAIN 23 0.0023
642 LIVER DISORDER 103 0.0023
643 DECREASED ACTIVITY 25 0.0023
644 NODULE 30 0.0023
645 MUSCLE ATROPHY 29 0.0023
646 HAEMOGLOBIN DECREASED 235 0.0023
647 ASTHENIA 858 0.0023
648 HEPATIC FUNCTION ABNORMAL 85 0.0023
649 BLOOD LACTATE DEHYDROGENASE INCREASED 36 0.0023
650 HYPERCALCAEMIA 28 0.0023
651 COVID-19 396 0.0023
652 MENTAL DISORDER 98 0.0022
653 AGEUSIA 56 0.0022
654 DERMATITIS 47 0.0022
655 BRAIN FOG 35 0.0022
656 BLOOD CALCIUM DECREASED 25 0.0022
657 HYPOCALCAEMIA 42 0.0022
658 PHARYNGITIS STREPTOCOCCAL 24 0.0022
659 NO THERAPEUTIC RESPONSE 27 0.0022
660 DRUG INEFFECTIVE 2908 0.0022
661 SKIN REACTION 31 0.0022
662 PREMATURE BABY 66 0.0022
663 WOUND INFECTION 24 0.0022
664 VERTIGO 133 0.0022
665 LETHARGY 125 0.0022
666 LIMB INJURY 59 0.0022
667 COLITIS 82 0.0022
668 BLOOD PRESSURE ABNORMAL 43 0.0022
669 HYPERSOMNIA 62 0.0022
670 PLATELET COUNT INCREASED 28 0.0021
671 GASTROENTERITIS 31 0.0021
672 GENERALISED TONIC-CLONIC SEIZURE 35 0.0021
673 ATAXIA 25 0.0021
674 MYDRIASIS 27 0.0021
675 NEURALGIA 51 0.0021
676 MYOCARDITIS 24 0.0021
677 HYPOGLYCAEMIA 101 0.0021
678 DENTAL CARIES 23 0.0021
679 PALLOR 56 0.0021
680 VOMITING 964 0.0020
681 DIARRHOEA 1322 0.0020
682 RASH GENERALISED 53 0.0020
683 CHOLELITHIASIS 67 0.0020
684 ABDOMINAL DISTENSION 213 0.0020
685 HYPOPHAGIA 52 0.0020
686 HEAD DISCOMFORT 36 0.0020
687 DYSPHAGIA 192 0.0020
688 FEEDING DISORDER 41 0.0020
689 FATIGUE 1572 0.0020
690 BRADYCARDIA 107 0.0020
691 ABDOMINAL PAIN 469 0.0020
692 IMMUNODEFICIENCY 30 0.0020
693 HAEMATEMESIS 51 0.0020
694 SEIZURE 232 0.0020
695 HIATUS HERNIA 26 0.0020
696 LIVER INJURY 49 0.0020
697 EPILEPSY 61 0.0020
698 MADAROSIS 23 0.0020
699 SKIN DISCOLOURATION 91 0.0020
700 BURSITIS 24 0.0020
701 PRODUCT PRESCRIBING ISSUE 43 0.0020
702 SNEEZING 44 0.0020
703 ADVERSE REACTION 26 0.0020
704 DEHYDRATION 261 0.0020
705 ABDOMINAL DISCOMFORT 328 0.0020
706 MOUTH ULCERATION 41 0.0019
707 FEELING COLD 54 0.0019
708 ABDOMINAL PAIN UPPER 399 0.0019
709 FEAR 52 0.0019
710 PANCREATITIS 102 0.0019
711 ARRHYTHMIA 91 0.0019
712 PRODUCT TASTE ABNORMAL 26 0.0019
713 NASOPHARYNGITIS 352 0.0019
714 CHROMATURIA 43 0.0019
715 TOXICITY TO VARIOUS AGENTS 321 0.0019
716 LOCALISED INFECTION 46 0.0019
717 BALANCE DISORDER 164 0.0019
718 HAEMORRHOIDS 37 0.0019
719 HALLUCINATION, VISUAL 40 0.0019
720 NAUSEA 1493 0.0019
721 SLEEP APNOEA SYNDROME 36 0.0019
722 KIDNEY INFECTION 37 0.0019
723 SEROTONIN SYNDROME 36 0.0019
724 HIP FRACTURE 60 0.0019
725 LIP SWELLING 62 0.0019
726 ANAPHYLACTIC SHOCK 48 0.0019
727 HEART RATE IRREGULAR 42 0.0019
728 BLOOD IRON DECREASED 22 0.0019
729 RASH 806 0.0018
730 OSTEOPOROSIS 76 0.0018
731 MACULAR DEGENERATION 22 0.0018
732 PRODUCT ADMINISTRATION ERROR 37 0.0018
733 HEMIPARESIS 31 0.0018
734 HEART RATE DECREASED 64 0.0018
735 ATRIAL FIBRILLATION 177 0.0018
736 DELIRIUM 63 0.0018
737 ADRENAL INSUFFICIENCY 22 0.0018
738 BONE DISORDER 33 0.0018
739 RASH PRURITIC 98 0.0018
740 URINARY TRACT INFECTION 308 0.0018
741 ANOSMIA 26 0.0018
742 CONTRAINDICATED PRODUCT ADMINISTERED 54 0.0018
743 HEADACHE 1117 0.0018
744 SWELLING FACE 116 0.0018
745 NECK PAIN 99 0.0018
746 DIPLOPIA 46 0.0018
747 PULMONARY EMBOLISM 168 0.0018
748 FOOT FRACTURE 33 0.0017
749 FEELING JITTERY 33 0.0017
750 DYSPEPSIA 170 0.0017
751 RED BLOOD CELL COUNT DECREASED 49 0.0017
752 CARDIAC FAILURE 137 0.0017
753 HEPATIC CIRRHOSIS 32 0.0017
754 OEDEMA 92 0.0017
755 CONVULSION 97 0.0017
756 CYSTITIS 54 0.0017
757 RASH PAPULAR 38 0.0017
758 INTERSTITIAL LUNG DISEASE 82 0.0017
759 CONSTIPATION 368 0.0017
760 IMPAIRED GASTRIC EMPTYING 23 0.0017
761 DYSURIA 62 0.0017
762 INFLUENZA LIKE ILLNESS 138 0.0017
763 THERAPY CESSATION 86 0.0017
764 CARDIO-RESPIRATORY ARREST 70 0.0017
765 PERICARDITIS 28 0.0017
766 DRY MOUTH 135 0.0017
767 PARAESTHESIA ORAL 24 0.0017
768 BLOOD POTASSIUM DECREASED 50 0.0017
769 TOOTHACHE 30 0.0017
770 COMPLICATION ASSOCIATED WITH DEVICE 24 0.0017
771 MATERNAL EXPOSURE DURING PREGNANCY 147 0.0016
772 STOMATITIS 100 0.0016
773 INJURY 115 0.0016
774 SCAR 28 0.0016
775 CONFUSIONAL STATE 264 0.0016
776 PREMATURE DELIVERY 26 0.0016
777 RASH MACULAR 57 0.0016
778 INCREASED APPETITE 31 0.0016
779 SPEECH DISORDER 85 0.0016
780 ANXIETY 461 0.0016
781 DIABETES MELLITUS 122 0.0016
782 FEELING ABNORMAL 383 0.0016
783 HYPOTHYROIDISM 51 0.0016
784 GASTRITIS 42 0.0016
785 HYPOAESTHESIA ORAL 24 0.0016
786 DIZZINESS 792 0.0016
787 BLOOD TRIGLYCERIDES INCREASED 28 0.0016
788 ARTHRITIS 124 0.0016
789 PANIC ATTACK 57 0.0016
790 MUSCULAR WEAKNESS 177 0.0016
791 APHASIA 47 0.0016
792 UPPER LIMB FRACTURE 31 0.0016
793 PAIN IN JAW 44 0.0016
794 HERNIA 30 0.0015
795 FLATULENCE 87 0.0015
796 ANAPHYLACTIC REACTION 84 0.0015
797 BACK PAIN 353 0.0015
798 GLOSSODYNIA 34 0.0015
799 MUSCLE TWITCHING 35 0.0015
800 DISCOMFORT 92 0.0015
801 HERPES ZOSTER 86 0.0015
802 GASTROINTESTINAL HAEMORRHAGE 125 0.0015
803 INTENTIONAL PRODUCT USE ISSUE 131 0.0015
804 PLATELET COUNT DECREASED 159 0.0015
805 BLOOD PRESSURE DECREASED 99 0.0015
806 UNDERDOSE 108 0.0015
807 FAECES DISCOLOURED 32 0.0015
808 ORAL PAIN 33 0.0015
809 DYSSTASIA 43 0.0015
810 BLOOD PRESSURE INCREASED 224 0.0015
811 RHABDOMYOLYSIS 61 0.0015
812 URTICARIA 245 0.0015
813 MUSCULOSKELETAL PAIN 76 0.0014
814 INTENTIONAL PRODUCT MISUSE 127 0.0014
815 EXPOSURE DURING PREGNANCY 90 0.0014
816 DEPRESSION 324 0.0014
817 RECTAL HAEMORRHAGE 61 0.0014
818 INTERVERTEBRAL DISC PROTRUSION 31 0.0014
819 HYPERTENSION 300 0.0014
820 DISABILITY 28 0.0014
821 DEEP VEIN THROMBOSIS 92 0.0014
822 OEDEMA PERIPHERAL 172 0.0014
823 BASAL CELL CARCINOMA 22 0.0014
824 ERYTHEMA 289 0.0014
825 IMPAIRED HEALING 46 0.0014
826 DISORIENTATION 55 0.0014
827 JOINT SWELLING 167 0.0014
828 PERIPHERAL SWELLING 213 0.0014
829 SWOLLEN TONGUE 43 0.0014
830 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 64 0.0014
831 ACCIDENTAL OVERDOSE 50 0.0014
832 DEPRESSED LEVEL OF CONSCIOUSNESS 54 0.0014
833 EMOTIONAL DISORDER 42 0.0014
834 SKIN ULCER 35 0.0014
835 PERITONITIS 28 0.0014
836 INCORRECT ROUTE OF DRUG ADMINISTRATION 48 0.0013
837 RESPIRATORY ARREST 37 0.0013
838 INSOMNIA 357 0.0013
839 CARDIAC DISORDER 124 0.0013
840 DEMENTIA 37 0.0013
841 WOUND 37 0.0013
842 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 94 0.0013
843 MELAENA 29 0.0013
844 SKIN EXFOLIATION 111 0.0013
845 PRODUCT PREPARATION ERROR 27 0.0013
846 ANGIOEDEMA 58 0.0013
847 WHITE BLOOD CELL COUNT DECREASED 142 0.0013
848 PRODUCT DOSE OMISSION IN ERROR 37 0.0013
849 PALPITATIONS 153 0.0013
850 GAIT DISTURBANCE 249 0.0013
851 HAEMORRHAGE 136 0.0013
852 POOR QUALITY SLEEP 28 0.0013
853 PRODUCT DISPENSING ERROR 28 0.0013
854 MIGRAINE 122 0.0013
855 OSTEOARTHRITIS 54 0.0013
856 CEREBRAL INFARCTION 31 0.0013
857 TREMOR 210 0.0013
858 PRODUCT PRESCRIBING ERROR 30 0.0013
859 NEUTROPHIL COUNT DECREASED 51 0.0013
860 BLOOD CREATINE PHOSPHOKINASE INCREASED 36 0.0012
861 LOWER LIMB FRACTURE 24 0.0012
862 DEPRESSED MOOD 66 0.0012
863 BLISTER 70 0.0012
864 THROMBOSIS 100 0.0012
865 AGITATION 91 0.0012
866 MUSCULOSKELETAL STIFFNESS 108 0.0012
867 IRRITABILITY 74 0.0012
868 MYALGIA 209 0.0012
869 MOOD SWINGS 39 0.0012
870 MEDICATION ERROR 68 0.0012
871 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 87 0.0012
872 CARDIAC FAILURE CONGESTIVE 98 0.0012
873 ADVERSE EVENT 112 0.0012
874 BLOOD URINE PRESENT 23 0.0012
875 GASTRIC ULCER 23 0.0012
876 PRURITUS 462 0.0012
877 AMNESIA 78 0.0012
878 FULL BLOOD COUNT DECREASED 24 0.0012
879 PROCEDURAL PAIN 33 0.0012
880 POLLAKIURIA 49 0.0012
881 SOMNOLENCE 235 0.0012
882 GASTRIC DISORDER 40 0.0012
883 WEIGHT INCREASED 261 0.0012
884 SYSTEMIC LUPUS ERYTHEMATOSUS 41 0.0012
885 FALL 383 0.0011
886 SYNCOPE 115 0.0011
887 URINARY INCONTINENCE 34 0.0011
888 DYSARTHRIA 43 0.0011
889 HYPERHIDROSIS 147 0.0011
890 FLUID RETENTION 58 0.0011
891 MUSCLE SPASMS 209 0.0011
892 OSTEONECROSIS OF JAW 28 0.0011
893 ECZEMA 59 0.0011
894 CORONARY ARTERY DISEASE 34 0.0011
895 EMOTIONAL DISTRESS 135 0.0011
896 DISTURBANCE IN ATTENTION 60 0.0011
897 PAIN 682 0.0011
898 URINARY RETENTION 37 0.0011
899 CONTUSION 106 0.0011
900 SWELLING 102 0.0011
901 CEREBRAL HAEMORRHAGE 39 0.0011
902 LABORATORY TEST ABNORMAL 32 0.0011
903 FOETAL EXPOSURE DURING PREGNANCY 88 0.0011
904 HYPOAESTHESIA 162 0.0011
905 GAIT INABILITY 36 0.0011
906 HALLUCINATION 81 0.0011
907 FREQUENT BOWEL MOVEMENTS 29 0.0011
908 MEMORY IMPAIRMENT 146 0.0011
909 PARAESTHESIA 167 0.0011
910 THERAPEUTIC RESPONSE DECREASED 64 0.0011
911 LOSS OF CONSCIOUSNESS 135 0.0011
912 DRY SKIN 140 0.0010
913 ANGINA PECTORIS 30 0.0010
914 ARTHRALGIA 433 0.0010
915 DIABETIC KETOACIDOSIS 25 0.0010
916 RESTLESSNESS 38 0.0010
917 OSTEONECROSIS 34 0.0010
918 TOOTH DISORDER 23 0.0010
919 MENTAL IMPAIRMENT 25 0.0010
920 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 30 0.0010
921 SKIN DISORDER 34 0.0010
922 CRYING 37 0.0010
923 HEAD INJURY 32 0.0010
924 INFUSION RELATED REACTION 67 0.0010
925 PRODUCT AVAILABILITY ISSUE 23 0.0010
926 HOT FLUSH 76 0.0010
927 FEMUR FRACTURE 31 0.0010
928 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 201 0.0010
929 ARTHROPATHY 55 0.0010
930 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 23 0.0010
931 NIGHTMARE 34 0.0010
932 ROAD TRAFFIC ACCIDENT 41 0.0010
933 NERVOUSNESS 50 0.0010
934 MOOD ALTERED 26 0.0010
935 ACUTE MYOCARDIAL INFARCTION 28 0.0009
936 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 170 0.0009
937 PAIN IN EXTREMITY 277 0.0009
938 MOVEMENT DISORDER 30 0.0009
939 BLOOD PRESSURE FLUCTUATION 22 0.0009
940 NEOPLASM MALIGNANT 61 0.0009
941 BURNING SENSATION 64 0.0009
942 DEVICE BREAKAGE 37 0.0009
943 FIBROMYALGIA 22 0.0009
944 BONE PAIN 53 0.0009
945 BLOOD CHOLESTEROL INCREASED 42 0.0009
946 BONE DENSITY DECREASED 28 0.0009
947 NO ADVERSE EVENT 161 0.0009
948 HAEMATOCHEZIA 49 0.0009
949 HAEMATOMA 23 0.0009
950 PRODUCT STORAGE ERROR 77 0.0009
951 ALOPECIA 171 0.0009
952 DIVERTICULITIS 24 0.0009
953 LIMB DISCOMFORT 26 0.0008
954 DRUG DOSE OMISSION 138 0.0008
955 ABNORMAL BEHAVIOUR 33 0.0008
956 CEREBROVASCULAR ACCIDENT 141 0.0008
957 BLOOD GLUCOSE DECREASED 39 0.0008
958 DEVICE DELIVERY SYSTEM ISSUE 22 0.0008
959 FEELING HOT 49 0.0008
960 PSYCHOTIC DISORDER 23 0.0008
961 DERMATITIS ATOPIC 41 0.0008
962 RHEUMATOID ARTHRITIS 88 0.0008
963 COGNITIVE DISORDER 35 0.0007
964 DRUG ADMINISTRATION ERROR 23 0.0007
965 ABORTION SPONTANEOUS 30 0.0007
966 BLOOD GLUCOSE INCREASED 141 0.0007
967 DYSKINESIA 30 0.0007
968 MOBILITY DECREASED 53 0.0007
969 INCORRECT DOSE ADMINISTERED 165 0.0007
970 THERAPEUTIC RESPONSE UNEXPECTED 32 0.0007
971 MYOCARDIAL INFARCTION 124 0.0007
972 ANGER 24 0.0007
973 LUNG NEOPLASM MALIGNANT 29 0.0007
974 PRODUCT QUALITY ISSUE 92 0.0007
975 EXPIRED PRODUCT ADMINISTERED 22 0.0007
976 FLUSHING 66 0.0006
977 ACCIDENTAL EXPOSURE TO PRODUCT 65 0.0006
978 PLASMA CELL MYELOMA 23 0.0006
979 ACNE 43 0.0006
980 SUICIDAL IDEATION 50 0.0005
981 DEVICE MALFUNCTION 38 0.0005
982 AGGRESSION 26 0.0005
983 DEVICE DIFFICULT TO USE 34 0.0005
984 OVERDOSE 110 0.0005
985 MALIGNANT NEOPLASM PROGRESSION 48 0.0005
986 PRODUCT SUBSTITUTION ISSUE 25 0.0004
987 INJECTION SITE SWELLING 30 0.0004
988 BREAST CANCER 22 0.0002
989 PSORIASIS 28 0.0002
990 INJECTION SITE ERYTHEMA 25 0.0002
991 INJECTION SITE PAIN 59 0.0002
992 DRUG DEPENDENCE 26 0.0002